Cargando…

Sponge-supported cultures of primary head and neck tumors for an optimized preclinical model

Treatment of advanced head and neck cancer is associated with low survival, high toxicity and a widely divergent individual response. The sponge-gel-supported histoculture model was previously developed to serve as a preclinical model for predicting individual treatment responses. We aimed to optimi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dohmen, Amy J.C., Sanders, Joyce, Canisius, Sander, Jordanova, Ekaterina S., Aalbersberg, Else A., van den Brekel, Michiel W.M., Neefjes, Jacques, Zuur, Charlotte L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982753/ https://www.ncbi.nlm.nih.gov/pubmed/29861851 http://dx.doi.org/10.18632/oncotarget.25244

Ejemplares similares

Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review
por: Dohmen, Amy J. C., et al.
Publicado: (2015)

Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity
por: Dohmen, Amy J.C., et al.
Publicado: (2017)

Quantitative Diffusion-Weighted Imaging Analyses to Predict Response to Neoadjuvant Immunotherapy in Patients with Locally Advanced Head and Neck Carcinoma
por: van der Hulst, Hedda J., et al.
Publicado: (2022)

[(18)F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma
por: Vos, Joris L., et al.
Publicado: (2021)

In vivo nerve identification in head and neck surgery using diffuse reflectance spectroscopy
por: Langhout, Gerrit C., et al.
Publicado: (2018)

A systematic review of validated assessments methods for head and neck lymphedema
por: Arends, Coralie R., et al.
Publicado: (2023)

Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy
por: Vossen, David M., et al.
Publicado: (2019)

ADC Values of Cytologically Benign and Cytologically Malignant 18 F-FDG PET-Positive Lymph Nodes of Head and Neck Squamous Cell Carcinoma
por: de Koekkoek-Doll, Petra K., et al.
Publicado: (2022)

Preclinical models in head and neck squamous cell carcinoma
por: Chaves, Patricia, et al.
Publicado: (2023)

Value of Assessing Peripheral Vascularization with Micro-Flow Imaging, Resistive Index and Absent Hilum Sign as Predictor for Malignancy in Lymph Nodes in Head and Neck Squamous Cell Carcinoma
por: de Koekkoek-Doll, Petra K., et al.
Publicado: (2021)

Ovarian cancer‐derived copy number alterations signatures are prognostic in chemoradiotherapy‐treated head and neck squamous cell carcinoma
por: Essers, Paul B.M., et al.
Publicado: (2020)

Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches
por: Miserocchi, Giacomo, et al.
Publicado: (2022)

Deterioration of Intended Target Volume Radiation Dose Due to Anatomical Changes in Patients with Head-and-Neck Cancer
por: Hamming-Vrieze, Olga, et al.
Publicado: (2021)

Aurantoside K, a New Antifungal Tetramic Acid Glycoside from a Fijian Marine Sponge of the Genus Melophlus
por: Kumar, Rohitesh, et al.
Publicado: (2012)

Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma
por: Navran, Arash, et al.
Publicado: (2023)

Feasibility of a supervised and home‐based tailored exercise intervention in head and neck cancer patients during chemoradiotherapy
por: Kok, Annemieke, et al.
Publicado: (2022)

Head and Neck Cancer Immunotherapy: Molecular Biological Aspects of Preclinical and Clinical Research
por: Chakraborty, Rajdeep, et al.
Publicado: (2023)

TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer
por: Yegodayev, Ksenia M., et al.
Publicado: (2020)

Sentinel Node Detection in Head and Neck Malignancies: Innovations in Radioguided Surgery
por: Vermeeren, L., et al.
Publicado: (2009)

What the clinician wants to know: surgical perspective and ultrasound for lymph node imaging of the neck: Monday 3 October 2005, 14:00–16:00
por: van den Brekel, Michiel W M, et al.
Publicado: (2005)

Feasibility of Sentinel Node Biopsy in Head and Neck Melanoma Using a Hybrid Radioactive and Fluorescent Tracer
por: Brouwer, Oscar R., et al.
Publicado: (2011)

Demographic, clinical, lifestyle-related, and social-cognitive correlates of physical activity in head and neck cancer survivors
por: Buffart, Laurien M., et al.
Publicado: (2017)

Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer
por: Bothwell, Katelyn D., et al.
Publicado: (2016)

Preclinical Head and Neck Squamous Cell Carcinoma Models for Combined Targeted Therapy Approaches
por: Schoenwaelder, Nina, et al.
Publicado: (2022)

Cochlea sparing effects of intensity modulated radiation therapy in head and neck cancers patients: a long-term follow-up study
por: Theunissen, Eleonoor AR, et al.
Publicado: (2014)

Paragangliomas of the head and neck: a contemporary review
por: Graham, Nathan J, et al.
Publicado: (2022)

Patterns of Hearing Loss in Irradiated Survivors of Head and Neck Rhabdomyosarcoma
por: Diepstraten, Franciscus A., et al.
Publicado: (2022)

HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings
por: Boschert, Verena, et al.
Publicado: (2020)

A preclinical model to investigate normal tissue damage following fractionated radiotherapy to the head and neck
por: Juvkam, Inga Solgård, et al.
Publicado: (2022)

Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer
por: Zerp, Shuraila F., et al.
Publicado: (2015)

Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma
por: Verhagen, Caroline V.M., et al.
Publicado: (2018)

(99m)Tc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy
por: Hoebers, Frank J. P., et al.
Publicado: (2007)

Into the Intracellular Logistics of Cross-Presentation
por: Neefjes, Jacques, et al.
Publicado: (2012)

Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma
por: Vos, Joris L., et al.
Publicado: (2021)

Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer Patients
por: van der Heijden, Martijn, et al.
Publicado: (2019)

Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications
por: van Harten, Anne M., et al.
Publicado: (2021)

Recent Clinical and Preclinical Advances in External Stimuli-Responsive Therapies for Head and Neck Squamous Cell Carcinoma
por: Jiang, Zheng, et al.
Publicado: (2022)

Correction to: A preclinical model to investigate normal tissue damage following fractionated radiotherapy to the head and neck
Publicado: (2023)

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
por: Valero, Cristina, et al.
Publicado: (2023)

Value of MR and CT Imaging for Assessment of Internal Carotid Artery Encasement in Head and Neck Squamous Cell Carcinoma
por: Lodder, W. L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u82io058nsejatblmiibdd9eke